159 related articles for article (PubMed ID: 28240400)
1. Low-dose prednisone and immunoglobulin G treatment for woman at risk for neonatal alloimmune thrombocytopenia and T helper 1 immunity.
Skariah A; Sung N; Salazar Garcia MD; Wu L; Tikoo A; Gilman-Sachs A; Kwak-Kim J
Am J Reprod Immunol; 2017 Jun; 77(6):. PubMed ID: 28240400
[TBL] [Abstract][Full Text] [Related]
2. New developments in fetal and neonatal alloimmune thrombocytopenia.
Bussel JB; Vander Haar EL; Berkowitz RL
Am J Obstet Gynecol; 2021 Aug; 225(2):120-127. PubMed ID: 33839095
[TBL] [Abstract][Full Text] [Related]
3. Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.
Lakkaraja M; Jin JC; Manotas KC; Vinograd CA; Ferd P; Gabor J; Wissert M; Berkowitz RL; McFarland JG; Bussel JB
Transfusion; 2016 Oct; 56(10):2449-2454. PubMed ID: 27611703
[TBL] [Abstract][Full Text] [Related]
4. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
5. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
6. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in understanding the pathogenesis of fetal and neonatal alloimmune thrombocytopenia.
Curtis BR
Br J Haematol; 2015 Dec; 171(5):671-82. PubMed ID: 26344048
[TBL] [Abstract][Full Text] [Related]
8. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
Kjeldsen-Kragh J; Ni H; Skogen B
Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
10. Antenatal interventions for fetomaternal alloimmune thrombocytopenia.
Rayment R; Brunskill SJ; Soothill PW; Roberts DJ; Bussel JB; Murphy MF
Cochrane Database Syst Rev; 2011 May; (5):CD004226. PubMed ID: 21563140
[TBL] [Abstract][Full Text] [Related]
11. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
[TBL] [Abstract][Full Text] [Related]
12. Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future.
Serrarens-Janssen VM; Semmekrot BA; Novotny VM; Porcelijn L; Lotgering FK; Delemarre FM; Steegers EA
Obstet Gynecol Surv; 2008 Apr; 63(4):239-52. PubMed ID: 18348738
[TBL] [Abstract][Full Text] [Related]
13. Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention.
Brojer E; Husebekk A; Dębska M; Uhrynowska M; Guz K; Orzińska A; Dębski R; Maślanka K
Arch Immunol Ther Exp (Warsz); 2016 Aug; 64(4):279-90. PubMed ID: 26564154
[TBL] [Abstract][Full Text] [Related]
14. Fetal and neonatal alloimmune thrombocytopenia.
Zdravic D; Yougbare I; Vadasz B; Li C; Marshall AH; Chen P; Kjeldsen-Kragh J; Ni H
Semin Fetal Neonatal Med; 2016 Feb; 21(1):19-27. PubMed ID: 26810319
[TBL] [Abstract][Full Text] [Related]
15. Fetal and neonatal alloimmune thrombocytopenia: a late or missed diagnosis disease in fetal and perinatal health-care settings.
Blanco S; Vega LC; Carrizo LH; Culasso JM; Gallego SV
J Matern Fetal Neonatal Med; 2022 Jan; 35(2):263-268. PubMed ID: 31973628
[TBL] [Abstract][Full Text] [Related]
16. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
17. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
Bonstein L; Haddad N
Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events.
Wienzek-Lischka S; Sawazki A; Ehrhardt H; Sachs UJ; Axt-Fliedner R; Bein G
Arch Gynecol Obstet; 2020 Aug; 302(2):355-363. PubMed ID: 32495019
[TBL] [Abstract][Full Text] [Related]
19. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
20. Neonatal alloimmune thrombocytopenia due to HPA-9b incompatibility.
Raj A; Kailasnath VP; Bertolone S; McFarland JG
Pediatr Blood Cancer; 2009 Sep; 53(3):459-61. PubMed ID: 19459189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
